Yidu Tech Inc. — M&A Activity 2026

Jun 1, 2026

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Yidu Tech Inc.

警渡科技有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 2158)

VOLUNTARY ANNOUNCEMENT

MEMORANDUM OF UNDERSTANDING IN RELATION TO PROPOSED ACQUISITION

This announcement is made by Yidu Tech Inc. (the "Company" or "Yidu Tech") on a voluntary basis.

MEMORANDUM OF UNDERSTANDING

The board of directors of the Company (the "Board") is pleased to announce that, on May 29, 2026 (after trading hours), the Company entered into a non-legally binding memorandum of understanding with an independent third party, in relation to a proposed acquisition (the "Proposed Acquisition") of 100% equity interests in a company principally engaged in the operation of an online doctors' platform and related services business (the "Target Company"). Under the terms of the non-legally binding memorandum of understanding, the consideration for the Proposed Acquisition is approximately RMB400 million (subject to the results of due diligence and the terms of the definitive transaction documents). Upon completion of the Proposed Acquisition, Yidu Tech through its designated nominee or subsidiary will hold 100% equity interests in the Target Company, and the Target Company will be consolidated into the financial statements of Yidu Tech.

INFORMATION ON THE TARGET COMPANY

The Target Company is principally engaged in the operation of an online doctors' platform and related services business (the "Core Business"). The Core Business has access to a substantial network of doctors. As at March 31, 2026, the platform had accumulated approximately 11 million registered users, including approximately 3.5 million practising doctor users.

---

Based on the information currently available to the Company and subject to further due diligence, for the financial year ended December 31, 2025, the revenue of the Core Business was approximately RMB167 million, the net profit of the Core Business was approximately RMB53 million (year on year increase of approximately 45.5%), and the net cash inflow from operating activities of the Core Business was approximately RMB14 million.

REASONS FOR AND BENEFITS OF THE PROPOSED ACQUISITION

The Board believes that the Proposed Acquisition, if materialised, would enable the Company to further integrate its leading artificial intelligence (“AI”) technology capabilities with the Target Company’s extensive doctor network, high-quality professional resources and established healthcare service channels, thereby strengthening the foundation for broader application of its AI capabilities in healthcare scenarios.

As at the date of this announcement, the parties have not entered into any definitive agreement in respect of the Proposed Acquisition. In the event that a definitive agreement is entered into, the Company will make further announcement(s) as and when appropriate in compliance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

The shareholders of the Company and potential investors are advised to exercise caution when dealing in the shares of the Company.

By order of the Board

Yidu Tech Inc.

Gong Yingying

Executive Director and Chairlady

Hong Kong, June 1, 2026

As at the date of this announcement, the executive Directors are Ms. Gong Yingying, Mr. Xu Jiming and Ms. Feng Xiaoying; the non-executive Director is Mr. Zeng Ming; and the independent non-executive Directors are Dr. Ma Wei-Ying, Ms. Pan Rongrong and Prof. Zhang Linqi.